In breast cancer, the expression of IGFBPL1 is regulated by aberrant hypermethylation, implying that the down-regulation of IGFBPL1 is involved in the pathogenesis of this malignancy [13]. The gene discussed is IGFBPL1; the disease is breast cancer.